Welcome to our Approved Ligands section, meticulously curated for the dynamic realm of scientific services and research and development (R&D) in pharmacology, drug discovery, and therapeutic development. Explore our comprehensive collection of high-quality ligands meticulously vetted and approved for various biomedical applications. From small molecules targeting specific receptors and pathways to biologics and antibody-based therapies, our selection includes compounds with proven efficacy and safety profiles, approved by regulatory agencies worldwide. Whether you're conducting preclinical studies, investigating drug mechanisms, or developing novel therapies, our Approved Ligands offer reliability, precision, and regulatory compliance for your scientific services and R&D endeavors. Discover the potential of approved ligands in accelerating your research and development efforts.
Approved Ligands
- Lithium, Inhibitor of glycogen synthase kinase 3 beta;Inhibitor of IMPase 1
Cas#:7439-93-2
Starting at $99.90
- Zofenopril-d5, Inhibitor of Angiotensin-converting enzyme
Cas#:81872-10-8 unlabeled
Starting at $332.90
- Regadenoson, Agonist of A 1 receptor;Agonist of A 2A receptor;Agonist of A 2B receptor;Agonist of A 3 receptor
Cas#:313348-27-5
Starting at $73.90